Advanced search
Publication Cover
Renal Failure Volume 40, 2018 - Issue 1
Submit an article Journal homepage
1,159
Views
14
CrossRef citations to date
0
Altmetric
Clinical Study

Urinary protein and renal prognosis in idiopathic membranous nephropathy: a multicenter retrospective cohort study in Japan

Makoto YamaguchiMunicipal Yokkaichi Hospital, Yokkaichi, Japan; View further author information
,
Masahiko AndoCenter for Advanced Medicine and Clinical Research, Nagoya University Hospital, Nagoya, Japan; View further author information
,
Takayuki KatsunoDepartment of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, JapanView further author information
,
Naotake TsuboiDepartment of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, JapanView further author information
&
Shoichi MaruyamaDepartment of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, JapanCorrespondence[email protected]
View further author information
Pages 435-441 | Received 08 Jan 2018, Accepted 07 Jun 2018, Published online: 27 Jul 2018

References

  • Fervenza FC, Sethi S, Specks U. Idiopathic membranous nephropathy: diagnosis and treatment. Clin J Am Soc Nephrol. 2008;3:905–919.
  • Cattran DC. Idiopathic membranous glomerulonephritis. Kidney Int. 2001;59:1983–1994.
  • Cattran D. Management of membranous nephropathy: when and what for treatment. J Am Soc Nephrol. 2005;16:1188–1194.
  • Laluck BJ, Jr, Cattran DC. Prognosis after a complete remission in adult patients with idiopathic membranous nephropathy. Am J Kidney Dis. 1999;33:1026–1032.
  • Troyanov S, Wall CA, Miller JA, et al. Idiopathic membranous nephropathy: definition and relevance of a partial remission. Kidney Int. 2004;66:1199–1205.
  • Eriguchi M, Oka H, Mizobuchi T, et al. Long-term outcomes of idiopathic membranous nephropathy in Japanese patients treated with low-dose cyclophosphamide and prednisolone. Nephrol Dial Transplant. 2009;24:3082–3088.
  • Yoshimoto K, Yokoyama H, Wada T, et al. Pathologic findings of initial biopsies reflect the outcomes of membranous nephropathy. Kidney Int. 2004;65:148–153.
  • Yamaguchi M, Ando M, Yamamoto R, et al. Smoking is a risk factor for the progression of idiopathic membranous nephropathy. PLoS One. 2014;9:e100835
  • Yamaguchi M, Ando M, Yamamoto R, et al. Patient age and the prognosis of idiopathic membranous nephropathy. PLoS One. 2014;9:e110376.
  • Matsushita K, Chen J, Sang Y, et al. Risk of end-stage renal disease in Japanese patients with chronic kidney disease increases proportionately to decline in estimated glomerular filtration rate. Kidney Int. 2016;90:1109–1114.
  • Badve SV, Palmer SC, Hawley CM, et al. Glomerular filtration rate decline as a surrogate end point in kidney disease progression trials. Nephrol Dial Transplant. 2016;31:1425–1436.
  • Hofstra JM, Wetzels JF. Management of patients with membranous nephropathy. Nephrol Dial Transplant. 2012;27:6–9.
  • Matsuo S, Imai E, Horio M, et al. Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–992.
  • Shiiki H, Saito T, Nishitani Y, et al. Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan. Kidney Int. 2004;65:1400–1407.
  • KDIGO Working Group. KDIGO clinical practice guideline for glomerulonephritis. Kidney Int Suppl. 2012;2:186–197.
  • Zent R, Nagai R, Cattran DC. Idiopathic membranous nephropathy in the elderly: a comparative study. Am J Kidney Dis. 1997;29:200–206.
  • Passerini P, Como G, Viganò E, et al. Idiopathic membranous nephropathy in the elderly. Nephrol Dial Transplant. 1993;8:1321.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.